Alligator Bioscience AB (publ) appointed Dr. Sumeet Ambarkhane as its Chief Medical Officer earlier 2022. BioStock reached out to Dr. Ambarkhane to learn more about his impressions and expectations in his new position.
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
0.895 SEK | +0.34% | +9.24% | +32.08% |
EPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+32.08% | 63.23M | |
+41.79% | 54.04B | |
-0.56% | 41.92B | |
+48.83% | 41.96B | |
-7.20% | 28.35B | |
+12.59% | 26.35B | |
-21.51% | 19B | |
+6.92% | 13B | |
+24.91% | 12.19B | |
+29.60% | 12.28B |
- Stock Market
- Equities
- ATORX Stock
- News Alligator Bioscience AB
- Alligator Bioscience AB Appoints Sumeet Ambarkhane as Its Chief Medical Officer